The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2022 | Unmet needs and emerging options for patients with PV
Aaron Gerds, MD, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, briefly discusses major unmet needs in polycythemia vera (PV), highlighting the importance of identifying patients at risk for clotting and the need to improve treatment options. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
Disclosures
Consulting/Advisory for CTI Biopharma, GSK/Sierra Oncology, Morphosys, ParmaEssentia, Imago, AbbVie
